We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current OPGN market cap is 16.38M. The company's latest EPS is USD -3.9099 and P/E is -0.50.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 699k | 1.07M | 168k | 28k | 0 |
| Operating Income | -3.57M | -16.96M | -1.7M | -1.59M | -783k |
| Net Income | -4.06M | -17.04M | 273k | -1.56M | 8.41M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 3.5M | 4.31M | 4.31M | 2.61M | 3.42M |
| Operating Income | -12.27M | -22.72M | -23.1M | -27.63M | -30.75M |
| Net Income | -12.45M | -26.08M | -41.97M | -37.28M | -32.67M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 18.14M | 1.88M | 2.97M | 2.87M | 5.47M |
| Total Liabilities | 15.46M | 13.44M | 13.68M | 14.54M | 2.48M |
| Total Equity | 2.68M | -11.56M | -10.71M | -11.67M | 2.99M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 10.42M | 49.75M | 71.67M | 25.81M | 1.88M |
| Total Liabilities | 6.13M | 28.56M | 30.45M | 18.24M | 13.44M |
| Total Equity | 4.29M | 21.19M | 41.22M | 7.58M | -11.56M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -12.64M | -14.32M | -1.08M | -1.81M | -4.64M |
| Investing | -799k | -800k | N/A | N/A | N/A |
| Financing | 6.28M | 8.37M | 200k | 821k | 5.12M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -11.51M | -23.4M | -21.48M | -20.45M | -14.32M |
| Investing | -2.5M | -1.06M | -1.98M | -591k | -800k |
| Financing | 12.17M | 34.09M | 47.45M | -6.74M | 8.37M |
| Market Cap | 16.38M |
| Price to Earnings Ratio | -0.50 |
| Price to Sales Ratio | 4.79 |
| Price to Cash Ratio | 14.21 |
| Price to Book Ratio | -1.42 |
| Dividend Yield | - |
| Shares Outstanding | 8.36M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.11 (5.58%) |
| Company Name | OpGen Inc |
| Address |
corporation trust center 1209 orange st wilmington, delaware 19801 |
| Website | https://www.opgen.com |
| Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
